Market revenue in 2023 | USD 1.4 million |
Market revenue in 2030 | USD 9.8 million |
Growth rate | 31.8% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Therapeutics, Diagnostics |
Key market players worldwide | Novartis AG ADR, Oncopeptides AB, Bicycle Therapeutics PLC ADR, AstraZeneca PLC, Theratechnologies Inc, Cybrexa Therapeutics, AngioChem, Soricimed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide drug conjugates market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 85.71% in 2023. Horizon Databook has segmented the Thailand peptide drug conjugates market based on therapeutics, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The competitive landscape of the peptide drug conjugate market in Thailand is marked by dynamic growth and strategic initiatives. As domestic and international pharmaceutical players recognize the country's potential as a hub for R&D, a flurry of activity has ensued, leading to heightened competition.
Local entities are forming collaborations with global counterparts, leveraging their expertise to advance peptide-based therapeutics. This collaborative synergy is driving innovation and diversification, fostering a vibrant ecosystem where novel drug candidates are being developed.
Furthermore, regulatory efforts to streamline approvals and facilitate clinical trials are attracting investments, intensifying the competitive dynamics, and positioning Thailand as an emerging player in the evolving peptide drug conjugate area.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand peptide drug conjugates market , including forecasts for subscribers. This country databook contains high-level insights into Thailand peptide drug conjugates market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account